Why Rodriguez faces lengthy suspension in baseball drug scandal

Fourteen professional baseball players are likely to be disciplined in a drug scandal involving a Florida anti-aging clinic. The Yankee's Alex Rodriguez (A-Rod), the highest payed player in the sport, is expected to be among the accused. 

|
AP Photo/Kathy Willens, File
In this file photo, New York Yankees' Alex Rodriguez speaks at a news conference during baseball spring training at Steinbrenner Field in Tampa, Fla. Rodriguez may face a lifetime suspension for his involvement with a Florida anti-aging clinic, Biogenesis of America.

Major League Baseball is threatening to kick Alex Rodriguez out of the game for life unless the New York Yankees star agrees not to fight a lengthy suspension for his role in the sport's latest drug scandal, according to a person familiar with the discussions.

The person spoke to The Associated Press on Wednesday on condition of anonymity because no statements were authorized.

Whether Commissioner Bud Selig would actually issue a lifetime suspension was unclear and a permanent ban could be shortened by arbitrator Fredric Horowitz to about 200 games, the person said.

The number of players likely to be disciplined stood at 14 Wednesday.

Front and center is Rodriguez, baseball's highest-paid player and the most prominent one linked in media reports over the past seven months to Biogenesis of America, a closed Florida anti-aging clinic that allegedly distributed banned performance-enhancing drugs.

The Yankees expected Rodriguez to be accused of recruiting other athletes for the clinic, attempting to obstruct MLB's investigation, and not being truthful with MLB in the past. Baseball has considered suspending him for violations of its labor contract and drug agreement.

Even if he is banned from baseball, there is precedent for a shortened penalty: When pitcher Steve Howe was given a lifetime ban in 1992 in his seventh suspension for drug or alcohol use, an arbitrator reduced the penalty to 119 days.

A three-time MVP, Rodriguez acknowledged four years ago that he used performance-enhancing substances while with Texas from 2001-03 but repeatedly has denied using them since.

He's been sidelined all season since hip surgery in January and then a quadriceps strain during a minor league rehabilitation assignment in July. The Yankees say he'll start another rehab Friday — Double-A Trenton appeared to be the likely destination.

"Hopefully Alex will be back shortly thereafter," Yankees general manager Brian Cashman said.

Rodriguez didn't stop to talk with reporters after his workout Wednesday at the team's minor league complex in Tampa, Fla.

At first, MLB and the union thought talks on the Biogenesis probe could be completed by Friday, but negotiations to avoid grievances are likely to push back announcements until at least Saturday or Sunday.

Others accused in media reports of receiving performance-enhancing drugs from Biogenesis include a trio of 2013 All-Stars: Texas outfielder Nelson Cruz, San Diego shortstop Everth Cabrera and Detroit shortstop Jhonny Peralta.

Most of the players face 50-game bans as first offenders. Both sides felt urgency to complete the process because by the middle of next week, teams will have fewer than 50 games left. And that would force players to complete suspensions during the playoffs or at the start of next season.

Detroit general manager Dave Dombrowski protected against a possible suspension of Peralta by acquiring slick-fielding infielder Jose Iglesias from Boston in a three-team trade Tuesday night.

"If it were a 15-day thing, like a typical injury, I think we could have comfortably dealt with it with the players we already have," Dombrowski said Wednesday. "But when you start to talk about 50 days and a possible playoff run, we feel better going ahead with Jose."

While MLB told the union which players it intends to suspend, it hasn't issued formal notices of discipline. Because of that, the countdown hasn't started under baseball's Joint Drug Agreement, which says the suspensions are effective on the third business day after the notice is issued.

The sides also haven't decided whether suspensions for first-time offenders who challenge the penalty can be announced before an arbitration decision.

If some stars knew their seasons were about to be cut short, they weren't letting on Wednesday, at least publicly.

"I can't talk about nothing right now. Just wait for the news," Cabrera said Wednesday before playing against Cincinnati.

Peralta thinks he shouldn't be on the list of players linked to Biogenesis.

"It's wrong," he said. "But whatever happens, I need to fight and try to move on."

Toronto outfielder Melky Cabrera, Oakland pitcher Bartolo Colon and San Diego catcher Yasmani Grandal were all suspended for 50 games last year for positive tests for elevated testosterone. MLB informed the union they won't receive additional discipline for that violation, two people familiar with the probe said. They also spoke on condition of anonymity because no statements were authorized.

"Nothing's been told to me," Melky Cabrera said. "I served my suspension last year, but MLB has never told me that it's OK now. I'm seeing it in the press, but I don't know."

Texas was unable to find a replacement bat to fill a void a suspension of Cruz would create.

"I don't think anybody's comfortable losing a significant part of your club, but it's out of our control," Rangers general manager Jon Daniels said. "We explored some deal like that. They just didn't come to a head. It wasn't for lack of interest or lack of effort. It was more lack of supply and lack of fit, really."

AP Baseball Writer Janie McCauley, AP Sports Writers Stephen Hawkins, Larry Lage and Bernie Wilson, and AP freelance writer Mark Didlter contributed to this report.

You've read  of  free articles. Subscribe to continue.
Real news can be honest, hopeful, credible, constructive.
What is the Monitor difference? Tackling the tough headlines – with humanity. Listening to sources – with respect. Seeing the story that others are missing by reporting what so often gets overlooked: the values that connect us. That’s Monitor reporting – news that changes how you see the world.

Dear Reader,

About a year ago, I happened upon this statement about the Monitor in the Harvard Business Review – under the charming heading of “do things that don’t interest you”:

“Many things that end up” being meaningful, writes social scientist Joseph Grenny, “have come from conference workshops, articles, or online videos that began as a chore and ended with an insight. My work in Kenya, for example, was heavily influenced by a Christian Science Monitor article I had forced myself to read 10 years earlier. Sometimes, we call things ‘boring’ simply because they lie outside the box we are currently in.”

If you were to come up with a punchline to a joke about the Monitor, that would probably be it. We’re seen as being global, fair, insightful, and perhaps a bit too earnest. We’re the bran muffin of journalism.

But you know what? We change lives. And I’m going to argue that we change lives precisely because we force open that too-small box that most human beings think they live in.

The Monitor is a peculiar little publication that’s hard for the world to figure out. We’re run by a church, but we’re not only for church members and we’re not about converting people. We’re known as being fair even as the world becomes as polarized as at any time since the newspaper’s founding in 1908.

We have a mission beyond circulation, we want to bridge divides. We’re about kicking down the door of thought everywhere and saying, “You are bigger and more capable than you realize. And we can prove it.”

If you’re looking for bran muffin journalism, you can subscribe to the Monitor for $15. You’ll get the Monitor Weekly magazine, the Monitor Daily email, and unlimited access to CSMonitor.com.

QR Code to Why Rodriguez faces lengthy suspension in baseball drug scandal
Read this article in
https://www.csmonitor.com/USA/Latest-News-Wires/2013/0731/Why-Rodriguez-faces-lengthy-suspension-in-baseball-drug-scandal
QR Code to Subscription page
Start your subscription today
https://www.csmonitor.com/subscribe